Skip to content
Search

Latest Stories

Charac raises £1.2m in debt and equity from NPA and pharmacy owners

Digital pharmacy app Charac has raised over £1 million in debt and equity, bringing total funding to date for the London-based startup to £2.5m.

Pharmacy Business understands while the majority of the new finance, worth about £1.2 million, comes from the National Pharmacy Association (NPA) coffer, the remainder is put forward by a number of individual pharmacy businesses.


The pharmacy sector is in a state of crisis, experiencing nearly two closures per week over the past two years, Charac said in a statement.

According to data from the NHS Business Services Authority, there are now only 11,026 community pharmacies in England, the lowest number since 2015. The current crisis is attributed to escalating operational costs, a shortage of staff, and diminished government financial support.

"In the long run, this is positive news," said Santosh Sahu, owner of the app. "However, at present, many pharmacies are primarily concerned with their survival and will find it challenging to meet the Government's envisioned expanded role for them. A significant number of Britain's pharmacies are not yet equipped to take on this added responsibility."

Charac’s statement further said that pharmacies will experience increased pressure after the Government's much talked-about Pharmacy First scheme is rolled out in England. Under this new scheme, patients with various ailments, such as sore throats or shingles, will be directed to local pharmacies before seeking assistance from their GPs.

Strategic alliance 

In 2022, the National Pharmacy Association (NPA), the trade association for 80 per cent of independent pharmacies across the UK, entered a strategic partnership with Charac, aiming to advance digital transition of independent community pharmacies.

“Our aim is also to help independents become more than a match for the national pharmacy chains in terms of their digital interface with patients,” Simon Tebbutt, Director of Membership, NPA told Pharmacy Business on Monday (September 11).

“Together, NPA, pharmacy owners and Charac will ensure that independent pharmacies can meet modern consumer expectations and adapt to the ever-evolving environment.”

Earlier, Charac secured a £1 million investment from Royal Mail, enabling direct home delivery of app-ordered prescriptions. The company said its discussions with prominent venture capitalist firms for additional funding were currently underway.

Meanwhile, Tebbutt emphasised that with this new investment, the NPA was strengthening its backing for innovation in the independent community pharmacy sector. "This stands as a clear strategic priority for the NPA and builds on prior successful investments in tech solutions, like Pro Delivery Manager," he said.

Pharmacies embrace the app

Charac's app is designed to address time constraints, improve efficiency, and support the growth of community pharmacies, while also enhancing recognition for their services. It enables pharmacists to handle repeat prescriptions, access patient records, schedule appointments, and conduct consultations.

“Charac's approach to patient engagement and emphasis on sector digitalisation, viewed as key initiatives to enhance prospects, is gaining traction among a growing number of pharmacies,” the company said.

The app has already garnered over 400 participating pharmacies, a number the company expects will reach 2,000 by 2024. Presently, approximately 25,000 patients utilise Charac's platform, and this figure is anticipated to surge to 100,000 by the end of the financial year in March 2024.

"Pharmacies that adopt innovative technology to increase capacity and offer clinical services will be better equipped to handle the sector's workforce and financial pressures," Tebbutt added.

More For You

Mike Hewitson, superintendent pharmacist & managing director of Beaminster Pharmacy

Mike Hewitson elected as NPA board member for England

Mike Hewitson elected as NPA board member for England: New term begins April

Mike Hewitson, superintendent pharmacist & managing director ofBeaminster Pharmacy, has been elected as the next National Pharmacy Association (NPA) board member for England.

Since 2023, Hewitson has served as chair of Community Pharmacy Dorset. He is also a member of Somerset Council and a Non-Executive Director at HubRx.

Keep ReadingShow less
Store closures 2024: Chemists among hardest hit

Over 600 chemist shops belonging to multiples and chains were closed last year

Getty Images

35 shops closed per day last year, chemists worst affected

More shops are expected to exit the UK high streets driven by driven by rising operational costs and a continued shift towards online shopping and transactions.

According to figures from PwC, a total of 12,804 outlets operated by chains (those with five or more locations) exited high streets, shopping centres and retail parks in 2024 – equivalent to 35 closures per day.

Keep ReadingShow less
Empty pharmacy shelves due to UK medicine shortages.

The government has said it's investing up to £520m to manufacture more medicines

Pic credit: iStock

Brexit blamed for UK medicine shortages with "little sign of recovery"

The UK is facing “a worsening situation” with drugs shortages compared to the rest of Europe as a result of Brexit, according to the Nuffield Trust health thinktank.

It comes of the back of data that revealed that the department of health and social care (DHSC) received 1,938 notifications of disruptions to medicine supply last year – the highest in four years.

Keep ReadingShow less
Alert! Patients on Promixin should be switched to alternatives by 30 April

Promixin is licensed for treating chronic pulmonary infections caused by Pseudomonas aeruginosa in adults and children with cystic fibrosis

Getty Images

Medicine shortage: Promixin to be discontinued from May 2025

The Department of Health and Social Care (DHSC) and NHS England have issued a national patient safety alert regarding the upcoming shortage of Promixin (colistimethate).

The alert, issued on 17 March 2025, states that Promixin (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials (UDVs) will be discontinued from early May 2025, with stocks expected to be exhausted by this time.

Keep ReadingShow less
PAGB welcomes new vice-presidents and treasurer to Board

Rob Elliott and Bas Vorsteveld ( L-R)

Bas Vorsteveld will now oversee the Kenvue’s business in Northern Europe

PAGB appoints new vice-presidents and treasurer to Board

PAGB, the consumer healthcare association, has announced the appointment of two new vice-presidents and a treasurer to their Board.

Bas Vorsteveld, area managing director for Northern Europe at Kenvue, and Rob Elliott, OTC centre of excellence lead at Viatris, have been elected as vice-presidents.

Keep ReadingShow less